参考文献/References:
［1］ Hall TC, Garcea G, Metcalfe M, et al. Management of acute non cirrhotic and non malignant portal vein thrombosis: a systematic review［J］. World J Surg, 2011, 35: 2510 2520.
［2］ James AW, Rabl C, Westphalen AC, et al. Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review［J］. Arch Surg, 2009, 144: 520 526.
［3］ Ogren M, Bergqvist D, Bj?觟rck M, et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies［J］. World J Gastroenterol, 2006, 12: 2115 2119.
［4］ Handa P, Crowther M, Douketis JD. Portal vein thrombosis: a Clinician Oriented and practical review［J］. Clin Appl Thromb Hemost, 2013, 20: 498 506.
［5］ Valla D, Casadevall N, Huisse MG, et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders［J］. Gastroenterology, 1988, 94: 1063 1069.
［6］ Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis［J］. J Hepatol, 2004, 40: 736 741.
［7］ Condat B, Pessione F, Helene Denninger M, et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy［J］. Hepatology, 2000, 32: 466 470.
［8］ Belli L, Romani F, Sansalone CV, et al. Portal thrombosis in cirrhotics. A retrospective analysis［J］. Ann Surg, 1986, 203: 286 291.
［9］ Nonami T, Yokoyama I, Iwatsuki S, et al. The incidence of portal vein thrombosis at liver transplantation［J］. Hepatology, 1992, 16: 1195 1198.
［10］ Pirisi M, Avellini C, Fabris C, et al. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study［J］. J Cancer Res Clin Oncol, 1998, 124: 397 400.
［11］ Arora NK, Lodha R, Gulati S, et al. Portal hypertension in North Indian children［J］. Indian J Pediatr, 2000, 65: 585 591.
［12］ Denninger MH, Cha?觙t Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors［J］. Hepatology, 2000, 31: 587 591.
［13］ Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management［J］. J Hepatol, 2000, 32: 865 871.
［14］ Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy［J］. Gastroenterology, 2001, 120: 490 497.
［15］ Battistelli S, Coratti F, Gori T. Porto spleno mesenteric venous thrombosis［J］. Int Angiol, 2011, 30: 1 11.
［16］ Ponziani FR, Zocco MA, Campanale C, et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment［J］. World J Gastroenterol, 2010, 16: 143 155.
［17］ Parikh S, Shah R, Kapoor P. Portal vein thrombosis［J］. Am J Med, 2010, 123: 111 119.
［18］ Janssen HL, Wijnhoud A, Haagsma EB, et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival［J］. Gut, 2001, 49: 720 724.
［19］ Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome［J］. Transplantation, 2000, 69: 1873 1881.
［20］ Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor Ⅴ leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd Chiari syndrome and portal vein thrombosis: results of a case control study［J］. Blood, 2000, 96: 2364 2368.
［21］ Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction［J］. Hepato logy, 2005, 41: 603 608.
［22］ De Stefano V, Teofili L, Leone G, et al. Spontaneous erythroid colony formation as the Clue to an underlying myeloproliferative disorder in patients with Budd Chiari syndrome or portal vein thrombosis［J］. Semin Thromb Hemost, 1997, 23: 411 418.
［23］ Dentali F, Galli M, Gianni M, et al. Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta analysis［J］. Thromb Haemost, 2008， 99： 675 682.
［24］ Hoekstra J, Janssen HL. Vascular liver disorders (Ⅱ): portal vein thrombosis［J］. Neth J Med, 2009, 67: 46 53.
［25］ Fisher NC, Wilde JT, Roper J, et al. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?［J］. Gut, 2000, 46: 534 539.
［26］ Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis［J］. Aliment Pharmacol Ther, 2009, 30: 881 894.
［27］ Chaffanjon PC, Brichon PY, Ranchoup Y, et al. Portal vein thrombosis following splenectomy for hematologic disease: prospective study with Doppler color flow imaging［J］. World J Surg, 1998, 22: 1082 1086.
［28］ Malkowski P, Pawlak J, Michalowicz B, et al. Thrombolytic treatment of portal thrombosis［J］. Hepatogastroenterology, 2003, 50: 2098 2100.
［29］ Valla DC. Portal vein thrombosis［A］. In: Deleve LD, Garcia Tsao G, eds. Vascular liver disease: Mechanisms and management［M］. New York, Dordrecht Heidelberg, London: Springer Science + Bussiness Media, 2011: 183 196.
［30］ Amitrano L, Guardascione MA, Scaglione M, et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses［J］. Am J Gastroenterol, 2007, 102: 2464 2470.
［31］ Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis［J］. N Engl J Med, 2001, 345: 1683 1688.
［32］ Tessler FN, Gehring BJ, Gomes AS, et al. Diagnosis of portal vein thrombosis: value of color Doppler imaging［J］. AJR Am J Roentgenol, 1991, 157: 293 296.
［33］ Danila M, Sporea I, Popescu A, et al. The value of contrast enhanced ultrasound in the evaluation of the Nature of portal vein thrombosis［J］. Med Ultrason, 2011, 13: 102 107.
［34］ Duran R, Denys AL, Letovanec I, et al. Multidetector CT features of mesenteric vein thrombosis［J］. Radiographics, 2012, 32: 1503 1522.
［35］ Shah TU, Semelka RC, Voultsinos V, et al. Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates［J］. Liver Transpl, 2006, 12: 1682 1688.
［36］ Ueno N, Sasaki A, Tomiyama T, et al. Color doppler ultrasono graphy in the diagnosis of cavernous transformation of the portal vein［J］. J Clin Ultrasound, 1997, 25: 227 233.
［37］ De Gaetano AM, Lafortune M, Patriquin H, et al. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography［J］. AJR Am J Roentgenol, 1995, 165: 1151 1155.
［38］ Ohnishi K, Okuda K, Ohtsuki T, et al. Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Observations in ten patients［J］. Gastroenterology, 1984, 87: 1150 1153.
［39］ Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment［J］. BMC Gastroenterol, 2007; 7: 34.
［40］ Chandra R, Kapoor D, Tharakan A, et al. Portal biliopathy［J］. J Gastroenterol Hepatol, 2001, 16: 1086 1092.
［41］ Chait Y, Condat B, Cazals Hatem D, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis［J］. Br J Haematol, 2005, 129: 553 560.
［42］ Deleve LD, Valla DC, Garcia Tsao G. Vascular disorders of the liver［J］. Hepatology, 2009, 49: 1729 1764.
［43］ Turnes J, Garcia Pagan JC, Gonzalez M, et al. Portal hypertension related complications after acute portal vein thrombosis: impact of early anticoagulation［J］. Clin Gastroenterol Hepatol, 2008, 6: 1412 1417.
［44］ de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno Ⅳ consensus workshop on methodology of diagnosis and therapy in portal hypertension［J］. J Hepatol, 2005, 43: 167 176.
［45］ Senzolo M, M Sartori T, Rossetto V, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis［J］. Liver Int, 2012, 32: 919 927.
［46］ Plessier A, Darwish Murad S, Hernandez Guerra M, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow up study［J］. Hepatology, 2010, 51: 210 218.
［47］ Hollingshead M, Burke CT, Mauro MA, et al. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis［J］. J Vasc Interv Radiol, 2005, 16: 651 661.
［48］ Zhou W, Choi L, Lin PH, et al. Percutaneous transhepatic thrombectomy and pharmacologic thrombolysis of mesenteric venous thrombosis［J］. Vascular, 2007, 15: 41 45.
［49］ Aytekin C, Boyvat F, Kurt A, et al. Catheter directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis［J］. Eur J Radiol, 2001, 39: 80 82.
［50］ Ozkan U, Oguzkurt L, Tercan F, et al. Percutaneous transhepatic thrombolysis in the treatment of acute portal venous thrombosis［J］. Diagn Interv Radiol, 2006, 12: 105 107.
［51］ Dumortier J, Walter T, Guillaud O, et al. Transcatheter local thrombolysis in patients with extensive TIPS thrombosis［J］. Gastroenterol Clin Biol, 2010, 34: 721 725.
［52］ Adani GL, Baccarani U, Risaliti A, et al. Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery［J］. Cardiovasc Intervent Radiol, 2007, 30: 1222 1226.
［53］ Uflacker R. Applications of percutaneous mechanical thrombe ctomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis［J］. Tech Vasc Interv Radiol, 2003, 6: 59 69.
［54］ Lopera JE, Correa G, Brazzini A, et al. Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis［J］. J Vasc Surg, 2002, 36: 1058 1061.
［55］ Bilbao JI, Vivas I, Elduayen B, et al. Limitations of percutaneous techniques in the treatment of portal vein thrombosis［J］. Cardiovasc Intervent Radiol, 1999, 22: 417 422.
［56］ Gaba RC, Khiatani VL, Knuttinen MG, et al. Comprehensive review of TIPS technical complications and how to avoid them［J］. AJR Am J Roentgenol, 2011, 196: 675 685.
［57］ Garcia Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis［J］. Hepatology, 2007, 46: 922 938.
［58］ Schepke M, Kleber G, Nürnberg D, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis［J］. Hepatology, 2004, 40: 65 72.
［59］ Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis［J］. Gastroentero logy, 2002, 123: 1013 1019.
［60］ De La Pena J, Brullet E, Sanchez Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial［J］. Hepatology, 2005, 41: 572 578.
［61］ Orloff MJ, Orloff MS, Girard B, et al. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years’ experience with portal systemic shunt［J］. J Am Coll Surg, 2002, 194: 717 728.
［62］ Warren WD, Henderson JM, Millikan WJ, et al. Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis［J］. Ann Surg, 1988, 207: 623 634.
［63］ Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis—new insights into aetiology and management［J］. Aliment Pharmacol Ther, 2005, 21: 1 9.
［64］ Kitchens CS, Weidner MH, Lottenberg R. Chronic oral anticoa gulant therapy for extrahepatic visceral thrombosis is safe［J］. J Thromb Thrombolysis, 2007, 23: 223 228.
［65］ Amitrano L, Guardascione MA, Menchise A, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis［J］. J Clin Gastroenterol, 2010, 44: 448 451.
［66］ Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension［J］. Hepatology, 2005, 41: 386 400.
［67］ Garcia Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding［J］. N Engl J Med, 2010, 362: 2370 2379.
［68］ Radosevich PM, Ring EJ, LaBerge JM, et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion［J］. Radiology, 1993, 186: 523 527.
［69］ 韩国宏， 孟祥杰， 殷占新， 等． 经皮脾静脉途径联合TIPS治疗伴海绵样变性的门静脉血栓［J］． 介入放射学杂志， 2009， 18： 177 181．
［70］ Bilbao JI, Quiroga J, Herrero JI, et al. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities［J］. Cardiovasc Intervent Radiol, 2002, 25: 251 269.
［71］ Luo J, Yan Z, Wang J, et al. Endovascular treatment for nonacute symptomatic portal venous thrombosis through intrahepatic portosystemic shunt approach［J］. J Vasc Interv Radiol, 2011, 22: 61 69.
［72］ Blum U, Haag K, R?觟ssle M, et al. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis［J］. Radiology, 1995, 195: 153 157.
［73］ Angermayr B, Cejna M, Koenig F, et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE covered stentgrafts versus bare stents［J］. Hepatology, 2003, 38: 1043 1050.
［74］ Bureau C, Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long term results of a randomized multicentre study［J］. Liver Int, 2007, 27: 742 747.
［75］ Senzolo M, Tibbals J, Cholongitas E, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation［J］. Aliment Pharmacol Ther, 2006, 23: 767 775.
［76］ Luca A, Miraglia R, Caruso S, et al. Short and long term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis［J］. Gut, 2011, 60: 846 852.
［77］ Wils A, van der linden E, van Hoek B, et al. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation［J］. J Clin Gastroen terol, 2009, 43: 982 984.
［78］ Chen L, Xiao T, Chen W, et al. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial［J］. Liver Int, 2009, 29: 1101 1109.
［79］ Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis［J］. J Hepatol, 2011, 54: 78 88.
［80］ Qi X, Han G, Yin Z, et al. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non cirrhotic patients［J］. Dig Dis Sci, 2012, 57: 1072 1082.
［81］韩国宏， 孟祥杰， 殷占新， 等． 经颈内静脉肝内门腔分流术及联合经皮肝/脾穿刺途径治疗门静脉血栓和（或）海绵样变性［J］． 中华医学杂志， 2009， 89： 1549 1552．
［82］李 说， 颜志平， 罗建均， 等． 经TIPS途径治疗急性、 亚急性门静脉血栓临床疗效［J］． 介入放射学杂志， 2009， 18： 581 583．
［83］ 方主亭， 颜志平， 罗剑钧， 等． 门静脉海绵样变（CTPV）的介入治疗［J］． 复旦学报·医学版， 2012， 39： 489 495．
［84］ Perarnau JM, Baju A. D’alteroche L, et al. Feasibility and long term evolution of TIPS in cirrhotic patients with portal thrombosis［J］. Eur J Gastroenterol Hepatol, 2010, 22: 1093 1098.
［85］贺辰龙， 崔进国， 苏秀琴， 等． 经颈静脉途径介入治疗门静脉血栓［J］． 介入放射学杂志， 2009， 18： 87 89．